Zevra Therapeutics EPS Diluted from Discontinued Operations (Quarterly) Analysis

Zevra Therapeutics, Inc. (ZVRA)

8.92 +0.54 (+6.44%) USD | NASDAQ | Jan 13, 16:00

8.92 0.00 (0.00%) After-Hours: 18:14

View EPS Diluted from Discontinued Operations (Quarterly) for ZVRA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Discontinued Operations (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Discontinued Operations (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Discontinued Operations (Quarterly) Benchmarks

Start Trial

XOMA Royalty Corp.	--
Verastem, Inc.	--
ADMA Biologics, Inc.	--
Akebia Therapeutics, Inc.	--
NovaBay Pharmaceuticals, Inc.	Upgrade